Cerebral Palsy Market Research Report – Forecast to 2027

Global Cerebral Palsy Market Research Report: By Type (Spastic Cerebral Palsy, Dyskinetic Cerebral Palsy, Hypotonic Cerebral Palsy, Ataxic Cerebral Palsy, Other), by Diagnosis (Imaging Tests, Others), by Treatment (Therapy, Medication, Other)– Forecast Till 2027

ID: MRFR/Pharma/4873-HCR | February 2021 | Region: Global | 90 pages

Please note that the assessment period of report has been updated from 2018-2023 to 2020-2027. Cordially fill the sample form for updated data.

Market Scenario


The global cerebral palsy market is expected to grow significantly over the forecast period. Cerebral palsy (CP) refers to a group of neurological conditions that affect muscle movement and coordination. CP can be caused by damage that occurs to the immature developing brain of an infant. In addition to this, other possible causes of CP include asphyxia neonatorum, bleeding into the brain, brain infections, and severe jaundice in the infants. Cerebral palsy is the most common form of childhood disability. According to the Cerebral Palsy Guidance, around 10,000 babies are born each year in the US with cerebral palsy.


The global cerebral palsy market is driving owing to the growing prevalence of cerebral palsy coupled with increasing awareness about the condition. Moreover, the growing adoptions of medications for controlling the symptoms of the cerebral palsy are anticipated to propel the market growth. Additionally, increasing expenditure for the healthcare sector in developed economies and increasing insurance coverage contribute to the growth of the market.


Despite the drivers, side effects associated with medications and high treatment cost and lack of awareness in some developing regions may hamper the market growth during the assessment period.


Segmentation


The global cerebral palsy market has been segmented into type, diagnosis, and treatment.


The market, on the basis of type, has been segmented into spastic cerebral palsy, dyskinetic cerebral palsy, hypotonic cerebral palsy, ataxic cerebral palsy, and mixed cerebral palsy.


The market, by diagnosis, has been segmented into imaging tests and others. The imaging tests have been further segmented into magnetic resonance imaging (MRI), cranial ultrasound, computed tomography, and electroencephalogram.


The market, by treatment, has been segmented into therapy, medication, surgery, and others. The therapy segment has been segmented into nutrition therapy, hyperbaric oxygen therapy, occupational therapy, physical therapy, stem cell therapy, and others. The medication segment has been segmented into anti-convulsant drugs, muscle relaxants, anti-depressant drugs, anti-inflammatory drugs, and others. Further, the surgery segment has been segmented into orthopedic surgery and others.


The market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The cerebral palsy market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada.


The European cerebral palsy market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. 


The cerebral palsy market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The cerebral palsy market in the Middle East & Africa has been segmented into the Middle East and Africa.


Key players


Allergen Plc, Cellular Biomedicine Group, Merck & Co., Inc., Pfizer, Inc., GlaxoSmithKline Plc, Abbott Laboratories, Acorda Therapeutics, Inc., Medtronic, Meridigen Biotech Co., Ltd., GW Pharmaceuticals Plc, and Cell Cure Neurosciences Ltd. are some of the key players in the global cerebral palsy market.


Regional Market Summary


Global Cerebral Palsy Market Share (%), by Region, 2017


Cerebral Palsy Market Share


Source: Centers for Disease Control and Prevention (CDC), White Papers, Company Presentations, Annual Reports


Geographically, the Americas is anticipated to dominate the global cerebral palsy market owing to a well-developed healthcare sector, rising prevalence of cerebral palsy and growing healthcare expenditure. Additionally, favorable reimbursement scenario in this region and a relatively large number of research and development (R&D) activities contributes to the growth of the market.


Europe is expected to hold the second largest position in the global cerebral palsy market. The market growth in this region is attributed to the growing prevalence of cerebral palsy, availability of funds for research, and increasing healthcare expenditure. According to the data stated by the National Institute for Health and Care Excellence (NICE) in 2017, in the UK, it is estimated that 1 in 400 babies are born with cerebral palsy. It also stated that approximately 1,800 children diagnosed with CP each year.


The cerebral palsy market in Asia-Pacific region consists of countries namely China, Japan, Republic of Korea, India, Australia and Rest of Asia-Pacific. Asia-Pacific is anticipated to be the fastest growing region in the market due to the presence of a huge patient population, continuously developing economies, rising prevalence of cerebral palsy and increasing government funding for the healthcare sector.


On the other hand, the Middle East & Africa has the least share of the market. Majority of the market of this region is expected to be held by the Middle East region due to a well-developed healthcare sector and growing government initiatives for the healthcare sector.


Global Cerebral Palsy Market, by Type



  • Spastic Cerebral Palsy

  • Dyskinetic Cerebral Palsy

  • Hypotonic Cerebral Palsy

  • Ataxic Cerebral Palsy

  • Mixed Cerebral Palsy


Global Cerebral Palsy Market, by Diagnosis



  • Imaging Tests

  • Magnetic Resonance Imaging (MRI)

  • Cranial Ultrasound

  • Computed Tomography (CT)

  • Others


Global Cerebral Palsy Market, by Treatment



  • Therapy

  • Nutrition Therapy

  • Hyperbaric Oxygen Therapy

  • Occupational Therapy

  • Physical Therapy

  • Stem Cell Therapy

  • Others

  • Medication

  • Anti-Convulsant Drugs

  • Muscle Relaxants

  • Anti-Depressant Drugs

  • Anti-Inflammatory Drugs

  • Others

  • Surgery

  • Orthopedic Surgery


Global Cerebral Palsy Market, by Region



  • Americas



  • North America

  • US

  • Canada

  • South America



  • Europe



  • Western Europe

  • Germany

  • France

  • Italy

  • Spain

  • UK

  • Rest of Western Europe

  • Eastern Europe



  • Asia-Pacific



  • Japan

  • China

  • India

  • Australia

  • South Korea

  • Rest of Asia-Pacific



  • Middle East & Africa



  • Middle East

  • Africa


Intended Audience



  • Pharmaceutical Companies

  • Research and Development (R&D) Companies

  • Diagnostic Laboratories

  • Government Research Institutes

  • Academic Institutes and Universities



Frequently Asked Questions (FAQ) :


The Americas is expected to lead the Cerebral Palsy Market.

Increasing awareness about the condition and increasing insurance coverage are adding market growth.

High treatment cost and certain side effects may limit market growth.

Eminent players profiled in the Cerebral Palsy Market include Cell Cure Neurosciences Ltd, GW Pharmaceuticals Plc, Meridigen Biotech Co., Ltd., Medtronic, Acorda Therapeutics, Inc., Abbott Laboratories, GlaxoSmithKline Plc, Pfizer, Inc., Merck & Co., Inc., Cellular Biomedicine Group, and Allergen Plc.

Different strategies used by industry players to create a dominance in the Cerebral Palsy Market include acquisitions, product development, and joint ventures.

Table of Contents:

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

Chapter 5. Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

5.4 Pricing Analysis

Chapter 6. Global Cerebral Palsy Market, by Type

6.1 Introduction

6.2 Spastic Cerebral Palsy

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

6.3 Dyskinetic Cerebral Palsy

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

6.4 Hypotonic Cerebral Palsy

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

6.5 Ataxic Cerebral Palsy

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

6.6 Mixed Cerebral Palsy

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

Chapter 7. Global Cerebral Palsy Market, by Diagnosis

7.1 Introduction

7.2 Imaging Tests

7.2.1 Magnetic Resonance Imaging (MRI)

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

7.2.2 Cranial Ultrasound

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

7.2.3 Computerized Tomography (CT)

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

7.2.4 Electroencephalogram (EEG)

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

7.3 Others

Chapter 8. Global Cerebral Palsy Market, by Treatment

8.1 Introduction

8.2 Therapy

8.2.1 Nutrition Therapy

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

8.2.2 Hyperbaric Oxygen Therapy

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

8.2.3 Occupational Therapy

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

8.2.4 Physical Therapy

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

8.2.5 Stem Cell Therapy

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

8.2.6 Others

8.3 Medication

8.3.1 Anti-convulsant Drugs

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

8.3.2 Muscle Relaxants Drugs

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

8.3.3 Anti-depressants Drugs

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

8.3.4 Anti-inflammatory Drugs

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

8.3.5 Others

8.4 Surgery

8.4.1 Orthopedic Surgery

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

8.4.2 Others

8.5 Others

Chapter 9. Global Cerebral Palsy Market, by Region

9.1 Introduction

9.2 Americas

9.2.1 North America

9.2.1.1 US

9.2.1.2 Canada

9.2.2 South America

9.3 Europe

9.3.1 Western Europe

9.3.1.1 Germany

9.3.1.2 France

9.3.1.3 Italy

9.3.1.4 Spain

9.3.1.5 UK

9.3.1.6 Rest of Western Europe

9.3.2 Eastern Europe

9.4 Asia-Pacific

9.4.1 Japan

9.4.2 China

9.4.3 India

9.4.4 Australia

9.4.5 South Korea

9.4.6 Rest of Asia-Pacific

9.5 Middle East & Africa

9.5.1 Middle East

9.5.2 Africa

Chapter 10. Company Landscape

10.1 Introduction

10.2 Market Share Analysis

10.3 Key Development & Strategies

Chapter 11. Company Profiles

11.1 Allergen Plc

11.1.1 Company Overview

11.1.2 Product Overview

11.1.3 Financials Overview

11.1.4 Key Developments

11.1.5 SWOT Analysis

11.2 Cellular Biomedicine Group

11.2.1 Company Overview

11.2.2 Product Overview

11.2.3 Financial Overview

11.2.4 Key Developments

11.2.5 SWOT Analysis

11.3 Merck & Co., Inc.

11.3.1 Company Overview

11.3.2 Product Overview

11.3.3 Financial Overview

11.3.4 Key Development

11.3.5 SWOT Analysis

11.4 Pfizer, Inc.

11.4.1 Company Overview

11.4.2 Product Overview

11.4.3 Financial Overview

11.4.4 Key Development

11.4.5 SWOT Analysis

11.5 GlaxoSmithKline plc

11.5.1 Company Overview

11.5.2 Product Overview

11.5.3 Financial overview

11.5.4 Key Developments

11.5.5 SWOT Analysis

11.6 Abbott Laboratories

11.6.1 Company Overview

11.6.2 Product Overview

11.6.3 Financial Overview

11.6.4 Key Developments

11.6.5 SWOT Analysis

11.7 Acorda Therapeutics, Inc.

11.7.1 Overview

11.7.2 Product Overview

11.7.3 Financial Overview

11.7.4 Key Developments

11.7.5 SWOT Analysis

11.8 Medtronic

11.8.1 Overview

11.8.2 Product Overview

11.8.3 Financials

11.8.4 Key Developments

11.8.5 SWOT Analysis

11.9 Meridigen Biotech Co., Ltd.

11.9.1 Overview

11.9.2 Product Overview

11.9.3 Financials

11.9.4 Key Developments

11.9.5 SWOT Analysis

11.10 GW Pharmaceuticals plc

11.10.1 Overview

11.10.2 Product Overview

11.10.3 Financials

11.10.4 Key Developments

11.10.5 SWOT Analysis

11.11 Cell Cure Neurosciences Ltd.

11.11.1 Overview

11.11.2 Product Overview

11.11.3 Financials

11.11.4 Key Developments

11.11.5 SWOT Analysis

Chapter 12 MRFR Conclusion

12.1 Key Findings

12.1.1 From CEO’s Viewpoint

12.1.2 Unmet Needs of the Market

12.2 Key Companies to Watch

12.3 Predictions for the Cerebral Palsy Industry

Chapter 13. Appendix

LIST OF TABLES

Table 1 Global Cerebral Palsy Market Synopsis, 2020–2027

Table 2 Global Cerebral Palsy Market Estimates and Forecast, 2020–2027 (USD Million)

Table 3 Global Cerebral Palsy Market, by Region, 2020–2027 (USD Million)

Table 4 Global Cerebral Palsy Market, by Type, 2020–2027 (USD Million)

Table 5 Global Cerebral Palsy Market, by Diagnosis, 2020–2027(USD Million)

Table 6 Global Cerebral Palsy Market, by Treatment, 2020–2027 (USD Million)

Table 7 North America: Cerebral Palsy Market, by Type, 2020–2027 (USD Million)

Table 8 North America: Cerebral Palsy Market, by Treatment, 2020–2027 (USD Million)

Table 9 North America: Cerebral Palsy Market, by Treatment, 2020–2027 (USD

Million)

Table 10 US: Cerebral Palsy Market, by Type, 2020–2027 (USD Million)

Table 11 US: Cerebral Palsy Market, by Diagnosis, 2020–2027 (USD Million)

Table 12 US: Cerebral Palsy Market, by Treatment, 2020–2027 (USD Million)

Table 13 Canada: Cerebral Palsy Market, by Type, 2020–2027 (USD Million)

Table 14 Canada: Cerebral Palsy Market, by Diagnosis, 2020–2027 (USD Million)

Table 15 Canada: Cerebral Palsy Market, by Treatment, 2020–2027 (USD Million)

Table 16 South America: Cerebral Palsy Market, by Type, 2020–2027 (USD Million)

Table 17 South America: Cerebral Palsy Market, by Diagnosis, 2020–2027 (USD Million)

Table 18 South America: Cerebral Palsy Market, by Treatment, 2020–2027 (USD

Million)

Table 19 Europe: Cerebral Palsy Market, by Type, 2020–2027 (USD Million)

Table 20 Europe: Cerebral Palsy Market, by Diagnosis, 2020–2027 (USD Million)

Table 21 Europe: Cerebral Palsy Market, by Treatment, 2020–2027 (USD Million)

Table 22 Western Europe: Cerebral Palsy Market, by Type, 2020–2027 (USD Million)

Table 23 Western Europe: Cerebral Palsy Market, by Diagnosis, 2020–2027 (USD Million)

Table 24 Western Europe: Cerebral Palsy Market, by Treatment, 2020–2027 (USD

Million)

Table 25 Eastern Europe: Cerebral Palsy Market, by Type, 2020–2027 (USD Million)

Table 26 Eastern Europe: Cerebral Palsy Market, by Diagnosis, 2020–2027 (USD Million)

Table 27 Eastern Europe: Cerebral Palsy Market, by Treatment, 2020–2027 (USD

Million)

Table 28 Asia-Pacific: Cerebral Palsy Market, by Type, 2020–2027 (USD Million)

Table 29 Asia-Pacific: Cerebral Palsy Market, by Diagnosis, 2020–2027 (USD Million)

Table 30 Asia-Pacific: Cerebral Palsy Market, by Treatment, 2020–2027 (USD Million)

Table 31 Middle East & Africa: Cerebral Palsy Market, by Type, 2020–2027

(USD Million)

Table 32 Middle East & Africa: Cerebral Palsy Market, by Diagnosis, 2020–2027 (USD Million)

Table 33 Middle East & Africa: Cerebral Palsy Market, by Treatment, 2020–2027

(USD Million)

LIST OF FIGURES

Figure 1 Research Process

Figure 2 Segmentation for Global Cerebral Palsy Market

Figure 3 Segmentation Market Dynamics for Global Cerebral Palsy Market

Figure 4 Global Cerebral Palsy Market Share, by Type, 2020

Figure 5 Global Cerebral Palsy Market Share, by Diagnosis, 2020

Figure 6 Global Cerebral Palsy Market Share, by Treatment, 2020

Figure 7 Global Cerebral Palsy Market Share, by Region, 2020

Figure 8 North America: Cerebral Palsy Market Share, by Country, 2020

Figure 9 Europe: Cerebral Palsy Market Share, by Country, 2020

Figure 10 Asia-Pacific: Cerebral Palsy Market Share, by Country, 2020

Figure 11 Middle East & Africa: Cerebral Palsy Market Share, by Country, 2020

Figure 12 Global Cerebral Palsy Market: Company Share Analysis, 2020 (%)

Figure 13 Allergen Plc: Key Financials

Figure 14 Allergen Plc: Segmental Revenue

Figure 15 Allergen Plc: Geographical Revenue

Figure 16 Cellular Biomedicine Group: Key Financials

Figure 17 Cellular Biomedicine Group: Segmental Revenue

Figure 18 Cellular Biomedicine Group: Geographical Revenue

Figure 19 Merck & Co., Inc.: Key Financials

Figure 20 Merck & Co., Inc.: Segmental Revenue

Figure 21 Merck & Co., Inc.: Geographical Revenue

Figure 22 Pfizer, Inc. : Key Financials

Figure 23 Pfizer, Inc: Segmental Revenue

Figure 24 Pfizer, Inc: Geographical Revenue

Figure 25 GlaxoSmithKline Plc: Key Financials

Figure 26 GlaxoSmithKline Plc: Segmental Revenue

Figure 27 GlaxoSmithKline Plc. Geographical Revenue

Figure 28 Abbott Laboratories: Key Financials

Figure 29 Abbott Laboratories: Segmental Revenue

Figure 30 Abbott Laboratories: Geographical Revenue

Figure 31 Acorda Therapeutics, Inc.: Key Financials

Figure 32 Acorda Therapeutics, Inc.: Segmental Revenue

Figure 33 Acorda Therapeutics, Inc.: Geographical Revenue

Figure 34 Medtronic: Key Financials

Figure 35 Medtronic: Segmental Revenue

Figure 36 Medtronic: Geographical Revenue

Figure 37 Meridigen Biotech Co., Ltd.: Key Financials

Figure 38 Meridigen Biotech Co., Ltd.: Segmental Revenue

Figure 39 Meridigen Biotech Co., Ltd.: Geographical Revenue

Figure 40 GW Pharmaceuticals plc: Key Financials

Figure 41 GW Pharmaceuticals plc: Segmental Revenue

Figure 42 GW Pharmaceuticals plc: Geographical Revenue

Figure 43 Cell Cure Neurosciences Ltd.: Key Financials

Figure 44 Cell Cure Neurosciences Ltd.: Segmental Revenue

Figure 45 Cell Cure Neurosciences Ltd.: Geographical Revenue